Übersetzung für "Alternative pathway" in Deutsch

Otherwise, complement activation occurs by an alternative pathway through special surface features of the foreign cells.

An alternative metabolic pathway is mediated by alanine glyoxylate transferase-2 (AGXT2).

The alternative NFkB signaling pathway is independent of IKK? and NEMO.

The existing route into the valley will remain as a second alternative pathway.

The alternative pathway of complement activation acts without the help of antibodies.

It is assumed that the activation in hemodialysis membranes takes place via the alternative pathway.

Essentially, the action of the catalyst is to provide an alternative, lower energy pathway for the reaction.

C3 glomerulopathy is a glomerular kidney disease caused by abnormal activation of the alternative complement pathway.

It is assumed that in the case of hemodialysis membranes composed of regenerated cellulose the activation takes place by the alternative pathway.

If antibodies against the invading organism are present, activation can be produced in a complement-specific manner by the complex of antibodies plus the antigen structures of the foreign cells; otherwise, complement activation takes place along an alternative pathway through special surface features of the foreign cells.

It is assumed that activation in hemodialysis membranes from regenerated cellulose takes place via the alternative pathway.

It is assumed that activation in hemodialysis membranes made of regenerated cellulose takes place via the alternative pathway.

If antibodies against the invading organism are present, the antibody with antigenic structures of the foreign cells can be activated in complement specific manner by the complex, otherwise the complement activation takes place by an alternative pathway due to special surface features of the foreign cells.

Promising starting points for these are offered by those pharmaceuticals which, in addition to inhibition of cyclooxygenase, intervene to an increased extent in the alternative pathway of arachidonic acid metabolism (by inhibiting, for example, 5-lipoxygenase and thus suppressing the excessive formation of the pro-inflammatory leukotrienes) and which may also have antioxidative properties and therefore deactivate the highly reactive oxygen free radicals which, as inflammatory mediators, cause progressive cell and tissue destruction in the rheumatic joints.

By contrast, factor I is a protease whose catalytic action is considerably increased by factor H and which inactivates the C3b molecule as well as the C4b molecule by partial degradation and thus intervenes in a regulatory/inhibitory manner at the merging of the “classical” and “alternative” pathway.

Although C1 inactivator alone inhibits contact activation of the classical pathway and thus also the subsequent release of the anaphylatoxins, it has no effect on the alternative pathway.

It is assumed that in the case of hemodialysis membranes made of regenerated cellulose, activation takes place by the alternative pathway.

When antibodies against the invading organism are present, complement-specific activation can occur from the complex of the antibodies with antigenic structures of the foreign cells; otherwise, complement activation occurs by an alternative pathway through special surface features of the foreign cells.

It is assumed that the activation in the case of hemodialysis membranes made of regenerated cellulose occurs by the alternative pathway.

The complement system can be activated through three pathways: the classical pathway, the alternative pathway, and the lectin pathway.

Students not qualifying for direct entry and seeking an alternative pathway into university can consider completing our associatedfoundation programme.

The common form of the syndrome is triggered by infection with Shiga toxin–producing bacteria and the less common form, about 10% of cases, called atypical hemolytic–uremic is related in approximately, 50% of patients with heterozygous loss-of-function mutations in genes encoding inhibitors of the alternative pathway of the complement system.

When antibodies against the invading organism are present, there can be complement-specific activation by the complex of the antibodies with antigenic structures of the foreign cells, otherwise complement activation takes place by an alternative pathway due to special surface features of the foreign cells.